News & Updates

CPSA 2026-03-04 CPSA 2026-03-04

PrescribeIT® concluding operations and TPP Alberta’s prescription requirements

CPSA 2025-09-16 CPSA 2025-09-16

Update: PrescribeIT® and TPP Type 1 prescribing requirements

CPSA 2025-07-08 CPSA 2025-07-08

How to navigate the TPP Atlas’ summary data

TPP Alberta is pleased to share the latest version of our online prescribing resource, the TPP Atlas.

CPSA 2025-07-03 CPSA 2025-07-03

Now available: 2024-25 TPP Annual Report

CPSA 2025-06-06 CPSA 2025-06-06

Use of PrescribeIT® - A reminder from TPP Alberta for prescribing Type 1 medications

CPSA 2025-04-17 CPSA 2025-04-17

Recent Steering Committee decisions: updates to Medication Lists

CPSA 2025-01-27 CPSA 2025-01-27

Lemborexant to Remain Monitored as a TPP Type 2 Medication

CPSA 2024-11-14 CPSA 2024-11-14

Extension of PrescribeIT Exemption

CPSA 2024-07-09 CPSA 2024-07-09

Now available: Interactive TPP Atlas

CPSA 2024-06-17 CPSA 2024-06-17

Updates on forgeries, medication lists and our program guide

CPSA 2024-03-11 CPSA 2024-03-11

Updated TPP Program Guide now available

CPSA 2023-12-15 CPSA 2023-12-15

Update: Narcotic Transitions Services Exemptions

CPSA 2023-11-03 CPSA 2023-11-03

Update: PrescribeIT and TPP Type 1 Prescribing Requirements

CPSA 2023-09-14 CPSA 2023-09-14

Update: PrescribeIT and TPP Type 1 Prescribing Requirements

CPSA 2023-07-24 CPSA 2023-07-24

Update on prescription forgeries

CPSA 2023-05-29 CPSA 2023-05-29

Reminder: prescribing high-potency narcotics for treatment of opioid use disorder

CPSA 2023-05-18 CPSA 2023-05-18

Now available: 2022-2023 TPP Annual Report

CPSA 2023-03-21 CPSA 2023-03-21

PrescribeIT and TPP Type 1 Prescribing Requirements

CPSA 2023-01-19 CPSA 2023-01-19

Hot off the press: the 2021 Opioid & Benzodiazepine/Z-drug and Antibiotic Prescription Atlases

CPSA 2022-11-16 CPSA 2022-11-16

Legislative changes impact treatment for opioid use disorder (OUD)

News & Updates

PrescribeIT® concluding operations and TPP Alberta’s prescription requirements

Update: PrescribeIT® and TPP Type 1 prescribing requirements

How to navigate the TPP Atlas’ summary data

Now available: 2024-25 TPP Annual Report

Use of PrescribeIT® - A reminder from TPP Alberta for prescribing Type 1 medications

Recent Steering Committee decisions: updates to Medication Lists

Lemborexant to Remain Monitored as a TPP Type 2 Medication

Extension of PrescribeIT Exemption

Now available: Interactive TPP Atlas

Updates on forgeries, medication lists and our program guide

Updated TPP Program Guide now available

Update: Narcotic Transitions Services Exemptions

Update: PrescribeIT and TPP Type 1 Prescribing Requirements

Update: PrescribeIT and TPP Type 1 Prescribing Requirements

Update on prescription forgeries

Reminder: prescribing high-potency narcotics for treatment of opioid use disorder

Now available: 2022-2023 TPP Annual Report

PrescribeIT and TPP Type 1 Prescribing Requirements

Hot off the press: the 2021 Opioid & Benzodiazepine/Z-drug and Antibiotic Prescription Atlases

Legislative changes impact treatment for opioid use disorder (OUD)

Contact TPP Alberta

Navigate the site

For partners